Innovative Medicines for Luxembourg
Acronym: IML
General Information
Identification Code: 256306032009-42
Website: [object Object]
Entity Form: ASBL
Registration Category: Trade and business associations
Registration Date: 7/10/2018
Last Update: 2/20/2024
EP Accredited Number: 0
Mission & Interests
Goals: Professional association for the innovative pharmaceutical industry in Luxembourg.
Information to members about access & regulatory framework in Luxembourg.
Advise NCA and Luxembourgish MEP in matters of EU health policies.
Interests Represented: Promotes their own interests or the collective interests of their members
Interests:
- Business and industry
- Institutional affairs
- Public health
- Research and innovation
Levels of Interest:
- national
- european
Activities
Main EU Legislative Proposals: - Falsified Medicines Directive 2011/61/UE
- EU regulation 469/2009 (SPCs)
- Directive 2001/83/EC on the Community code relating to medicinal products for human use
- Regulation (EC) No 726/2004 laying down Union procedures for the authorisation and supervision of medicinal products for human use and establishing a European Medicines Agency
- Regulation (EC) No 141/2000 on orphan medicinal products
- Regulation (EC) No 1901/2006 on medicinal products for paediatric use
Communication Activities: none
Inter-institutional or Unofficial Groupings: N/A
Head Office
Address: 7, rue Alcide de Gasperi
Post Code: 1615
City: Luxembourg
Country: LUXEMBOURG
Phone: [object Object]
EU Office
Address: 7, rue Alcide de Gasperi
Post Code: 1615
City: Luxembourg
Country: LUXEMBOURG
Phone: [object Object]
Financial Data
New Organisation: false
Closed Year: [object Object]
Current Year: [object Object]
Membership Information
Members10 Percent: 1
Members25 Percent: 1
Members50 Percent: 0
Members75 Percent: 0
Members: 2
Members F T E: 0.3499999940395355
Structure
Structure Type: Structure
Is Member Of: https://www.iml.lu/en/about-us/members
Organisation Members: 1)
https://www.lmvo.lu
2)
https://www.eupati.eu/luxembourg/